Cancer imaging is moving from a purely diagnostic tool to a source of measurable, reproducible data that can guide treatment decisions and trial outcomes.

Track Novartis India share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit & ...

Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) announced that the Phase II clinical study of its core product ...

Environmental groups say state regulators approved permits that allow pollution from an Ottumwa coal-ash landfill to continue ...

Researchers at Carnegie Mellon University in Qatar (CMU Q) have discovered a genetic molecule that could provide new ...

That balanced, evidence-driven approach has become a defining principle of UC San Diego’s AI strategy. Rather than asking ...

As a new study links consumption of our favourite pick-me-up to lower risk of cirrhosis, here’s how to reap the benefits ...

The approval allows the company to offer its PD-L1 IHC 22C3 pharmDx Code SK006 CDx for ovarian and other cancers.

Approval expands PD-L1 testing to support treatment decisions with KEYTRUDA (pembrolizumab) Agilent Technologies Inc. (NYSE: A) today announced it has received European Union (EU) certification for ...

PD-L1 IHC 22C3 pharmDx, Code SK006, was developed by Agilent in partnership with Merck (known as MSD outside of the United States and Canada) as a companion diagnostic for KEYTRUDA ®. KEYTRUDA ® is a ...

Hundreds of undergraduates from Duke and beyond spend their break in mentored research with Duke faculty, often diving into fields they‘d never touched in a classroom. Some build websites and short ...

A woman underwent chemotherapy and major surgery after a biopsy was wrongly diagnosed as cancer. In October 2023, the woman ...